Evidence map›Paper›PMID 31694722›Full record

ArticleGenome medicine2019

From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.

Anna Lindstrand, Jesper Eisfeldt, Maria Pettersson, Claudia M B Carvalho, Malin Kvarnung, Giedre Grigelioniene, Britt-Marie Anderlid, Olof Bjerin, Peter Gustavsson, Anna Hammarsjö and 20 more

Abstract read
In one paragraph

Article in Genome medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Anna LindstrandDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. anna.lindstrand@ki.se.ORCID http://orcid.org/0000-0003-0806-5602
Jesper EisfeldtDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Maria PetterssonDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Claudia M B CarvalhoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Malin KvarnungDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Giedre GrigelionieneDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Britt-Marie AnderlidDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Olof BjerinThe Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Peter GustavssonDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Anna HammarsjöDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Patrik Georgii-HemmingDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Erik IwarssonDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Maria Johansson-SollerDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Kristina Lagerstedt-RobinsonDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Agne LiedenDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Måns MagnussonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Marcel MartinDepartment of Biochemistry and Biophysics, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Stockholm University, Stockholm, Sweden.
Helena MalmgrenDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Magnus NordenskjöldDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Ameli NorlingThe Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Ellika SahlinDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Henrik StranneheimDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Emma ThamDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Josephine WincentDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Sofia YgbergThe Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Anna WedellDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Valtteri WirtaScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, Sweden.
Ann NordgrenDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Johanna LundinDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Daniel NilssonDepartment of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince different types of genetic variants, from single nucleotide variants (SNVs) to large chromosomal rearrangements, underlie intellectual disability, we evaluated the use of whole-genome sequencing (WGS) rather than chromosomal microarray analysis (CMA) as a first-line genetic diagnostic test.

methodsWe analyzed three cohorts with short-read WGS: (i) a retrospective cohort with validated copy number variants (CNVs) (cohort 1, n = 68), (ii) individuals referred for monogenic multi-gene panels (cohort 2, n = 156), and (iii) 100 prospective, consecutive cases referred to our center for CMA (cohort 3). Bioinformatic tools developed include FindSV, SVDB, Rhocall, Rhoviz, and vcf2cytosure.

resultsFirst, we validated our structural variant (SV)-calling pipeline on cohort 1, consisting of three trisomies and 79 deletions and duplications with a median size of 850 kb (min 500 bp, max 155 Mb). All variants were detected. Second, we utilized the same pipeline in cohort 2 and analyzed with monogenic WGS panels, increasing the diagnostic yield to 8%. Next, cohort 3 was analyzed by both CMA and WGS. The WGS data was processed for large (> 10 kb) SVs genome-wide and for exonic SVs and SNVs in a panel of 887 genes linked to intellectual disability as well as genes matched to patient-specific Human Phenotype Ontology (HPO) phenotypes. This yielded a total of 25 pathogenic variants (SNVs or SVs), of which 12 were detected by CMA as well. We also applied short tandem repeat (STR) expansion detection and discovered one pathologic expansion in ATXN7. Finally, a case of Prader-Willi syndrome with uniparental disomy (UPD) was validated in the WGS data. Important positional information was obtained in all cohorts. Remarkably, 7% of the analyzed cases harbored complex structural variants, as exemplified by a ring chromosome and two duplications found to be an insertional translocation and part of a cryptic unbalanced translocation, respectively.

conclusionThe overall diagnostic rate of 27% was more than doubled compared to clinical microarray (12%). Using WGS, we detected a wide range of SVs with high accuracy. Since the WGS data also allowed for analysis of SNVs, UPD, and STRs, it represents a powerful comprehensive genetic test in a clinical diagnostic laboratory setting.

Indexed as

Genetic MarkersGenome, HumanPolymorphism, Single NucleotideChildChromosome AberrationsCytogenetic AnalysisDiagnostic Tests, RoutineDNA Copy Number VariationsFemaleHumansIntellectual DisabilityMalePilot ProjectsProspective StudiesRetrospective StudiesWhole Genome SequencingGenetic MarkersCopy number variationIntellectual disabilityMonogenic diseaseRepeat expansionSingle nucleotide variantStructural variationUniparental disomyWhole-genome sequencing

Identifiers

PMID31694722
PMCPMC6836550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.